Consensus statement on the management of waldenström macroglobulinemia patients during the COVID-19 pandemic

Dipti Talaulikar; Ranjana H. Advani; Andrew R. Branagan; Christian Buske; Meletios A. Dimopoulos; Shirley D'Sa; Maria J. Kersten; Veronique Leblond; Monique C. Minnema; Roger G. Owen; Maria Lia Palomba; Alessandra Tedeschi; Judith Trotman; Marzia Varettoni; Josephine M. Vos; Steven P. Treon; Efstathios Kastritis; Jorge J. Castillo

doi:10.1097/HS9.0000000000000433

Consensus statement on the management of waldenström macroglobulinemia patients during the COVID-19 pandemic

Dipti Talaulikar^*, Ranjana H. Advani, Andrew R. Branagan, Christian Buske, Meletios A. Dimopoulos, Shirley D'Sa, Maria J. Kersten, Veronique Leblond, Monique C. Minnema, Roger G. Owen, Maria Lia Palomba, Alessandra Tedeschi, Judith Trotman, Marzia Varettoni, Josephine M. Vos, Steven P. Treon, Efstathios Kastritis, Jorge J. Castillo

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.

Original language	English
Article number	e443
Journal	HemaSphere
Volume	4
Issue number	4
DOIs	https://doi.org/10.1097/HS9.0000000000000433
Publication status	Published - 2020

Access to Document

10.1097/HS9.0000000000000433

Cite this

Talaulikar, D., Advani, R. H., Branagan, A. R., Buske, C., Dimopoulos, M. A., D'Sa, S., Kersten, M. J., Leblond, V., Minnema, M. C., Owen, R. G., Palomba, M. L., Tedeschi, A., Trotman, J., Varettoni, M., Vos, J. M., Treon, S. P., Kastritis, E., & Castillo, J. J. (2020). Consensus statement on the management of waldenström macroglobulinemia patients during the COVID-19 pandemic. HemaSphere, 4(4), Article e443. https://doi.org/10.1097/HS9.0000000000000433

@article{a971cd461acc448ea32b3e09a219a595,

title = "Consensus statement on the management of waldenstr{\"o}m macroglobulinemia patients during the COVID-19 pandemic",

abstract = "In the light of the COVID-19 pandemic, the International Workshop on Waldenstr{\"o}m Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenstr{\"o}m Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.",

author = "Dipti Talaulikar and Advani, {Ranjana H.} and Branagan, {Andrew R.} and Christian Buske and Dimopoulos, {Meletios A.} and Shirley D'Sa and Kersten, {Maria J.} and Veronique Leblond and Minnema, {Monique C.} and Owen, {Roger G.} and Palomba, {Maria Lia} and Alessandra Tedeschi and Judith Trotman and Marzia Varettoni and Vos, {Josephine M.} and Treon, {Steven P.} and Efstathios Kastritis and Castillo, {Jorge J.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2020",

doi = "10.1097/HS9.0000000000000433",

language = "English",

volume = "4",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "4",

}

Talaulikar, D, Advani, RH, Branagan, AR, Buske, C, Dimopoulos, MA, D'Sa, S, Kersten, MJ, Leblond, V, Minnema, MC, Owen, RG, Palomba, ML, Tedeschi, A, Trotman, J, Varettoni, M, Vos, JM, Treon, SP, Kastritis, E & Castillo, JJ 2020, 'Consensus statement on the management of waldenström macroglobulinemia patients during the COVID-19 pandemic', HemaSphere, vol. 4, no. 4, e443. https://doi.org/10.1097/HS9.0000000000000433

TY - JOUR

T1 - Consensus statement on the management of waldenström macroglobulinemia patients during the COVID-19 pandemic

AU - Talaulikar, Dipti

AU - Advani, Ranjana H.

AU - Branagan, Andrew R.

AU - Buske, Christian

AU - Dimopoulos, Meletios A.

AU - D'Sa, Shirley

AU - Kersten, Maria J.

AU - Leblond, Veronique

AU - Minnema, Monique C.

AU - Owen, Roger G.

AU - Palomba, Maria Lia

AU - Tedeschi, Alessandra

AU - Trotman, Judith

AU - Varettoni, Marzia

AU - Vos, Josephine M.

AU - Treon, Steven P.

AU - Kastritis, Efstathios

AU - Castillo, Jorge J.

N1 - Publisher Copyright: Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2020

Y1 - 2020

N2 - In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.

AB - In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.

UR - http://www.scopus.com/inward/record.url?scp=85097809728&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000433

DO - 10.1097/HS9.0000000000000433

M3 - Article

SN - 2572-9241

VL - 4

JO - HemaSphere

JF - HemaSphere

IS - 4

M1 - e443

ER -

Consensus statement on the management of waldenström macroglobulinemia patients during the COVID-19 pandemic

Abstract

Access to Document

Other files and links

Fingerprint

Cite this